Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
1984-8-13
pubmed:abstractText
When blood flows through Dacron arterial grafts, platelets adhere in large numbers to the luminal surface of the grafts. Different types of commercially available Dacron grafts vary in their level of thrombogenicity. This thrombogenic response has been evaluated in an artificial circulation and in patients with Dacron aorto-bifemoral grafts, and the response can be modified by the use of platelet-inhibitory drugs. A double blind trial has shown that when a combination of aspirin and dipyridamole is administered to patients with femoro-popliteal Dacron bypass grafts, then the patency rate of these grafts can be significantly improved.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0035-8843
pubmed:author
pubmed:issnType
Print
pubmed:volume
66
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
241-6
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1984
pubmed:articleTitle
The thrombogenicity of Dacron arterial grafts and its modification by platelet inhibitory drugs.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't